ART and Treatment

This policy brief provides antiretroviral therapy programme managers, implementing partners, procurement and supply chain managers, and other relevant stakeholders with key points to consider before and during the introduction of the new dosage form of ritonavir-boosted lopinavir (LPV/r) oral pellets.

In response to a longstanding demand for a heat-stable and easy to administer formulation of ritonavir boosted lopinavir (LPV/r) for infants and young children, a new formulation in pellet form is now available.

This fact sheet provides simplified information to facilitate proper dosing and administration of lopinavir and ritonavir 40mg/10mg oral pellets.

This compendium of case studies showcases innovative approaches to integrated HIV-SRH service delivery for improving MNCH outcomes, and strengthening health and community systems. It is hoped that the 11 case studies included in this publication will help to inform future programming by providing examples of promising practices related to integration in sub-Saharan Africa in order to extrapolate the common elements of, and barriers to, effective integrated service delivery.

This document provides guidance on monitoring and evaluating the implementation of the comprehensive package of interventions to address HIV among key populations: men who have sex with men, people in prisons and other closed settings, people who inject drugs, sex workers and transgender people.

This document provides countries with:

• a set of harmonized indicators to examine the implementation of the package of interventions to address HIV among key populations; and
• guidance on setting targets for these indicators.

This document updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

The purpose of this framework is to provide operational guidance on monitoring and evaluation of pregnant and breastfeeding women receiving ART for life and their HEIs. This document is organized around a series of recommendations for the operationalization of monitoring, both routine (Section 1) and enhanced (Section 2), and the evaluation (Section 3) of programmes implementing lifelong ART for pregnant and breastfeeding women and their infants.

The new Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.

The IMCI chart booklet is for use by doctors, nurses and other health professionals who see young infants and children less than five years old. It facilitates the use of the IMCI case management process in practice and describes a series of all the case management steps in a form of IMCI charts. 

These charts show the sequence of steps and provide information for performing them. The IMCI chart booklet should be used by all health professionals providing care to sick children to help them apply the IMCI case management guidelines. Health professionals should always use the chart booklet for easy reference. 

The chart booklet is divided into two main parts because clinical signs in sick young infants (up to 2 months) and older children (2 months to 5 years) are somewhat different and because case management procedures also differ between these age groups.